Literature DB >> 22582164

Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H).

Roger S Holmes, John L Vandeberg, Laura A Cox.   

Abstract

Cholesterol ester lipase (LIPA; EC 3.1.1.13) and cholesterol 25-hydroxylase (CH25H; EC 1.14.99.48) play essential role in cholesterol metabolism in the body by hydrolysing cholesteryl esters and triglycerides within lysosomes (LIPA) and catalysing the formation of 25-hydroxycholesterol from cholesterol (CH25H) which acts to repress cholesterol biosynthesis. Bioinformatic methods were used to predict the amino acid sequences, structures and genomic features of several vertebrate LIPA and CH25H genes and proteins, and to examine the phylogeny of vertebrate LIPA. Amino acid sequence alignments and predicted subunit structures enabled the identification of key sequences previously reported for human LIPA and CH25H and transmembrane structures for vertebrate CH25H sequences. Vertebrate LIPA and CH25H genes were located in tandem on all vertebrate genomes examined and showed several predicted transcription factor binding sites and CpG islands located within the 5' regions of the human genes. Vertebrate LIPA genes contained nine coding exons, while all vertebrate CH25H genes were without introns. Phylogenetic analysis demonstrated the distinct nature of the vertebrate LIPA gene and protein family in comparison with other vertebrate acid lipases and has apparently evolved from an ancestral LIPA gene which predated the appearance of vertebrates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13205-011-0013-9) contains supplementary material, which is available to authorized users.

Entities:  

Year:  2011        PMID: 22582164      PMCID: PMC3324826          DOI: 10.1007/s13205-011-0013-9

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


Introduction

Lysosomal acid lipase or cholesteryl ester hydrolase (also called lipase A or LIPA) (EC 3.1.1.13) catalyses the hydrolysis of cholesterol esters or triglycerides which have been localized within lysosomes following a receptor-mediated endocytosis of low-density lipoprotein (LDL) particles (Goldstein et al. 1975; Anderson et al. 1994; Wang et al. 2008). Inborn errors of metabolism for the human gene encoding this enzyme (LIPA) have been described, including Wolman disease (WOD), resulting from a major defect of the gene which leads to a cholesteryl ester storage disease and loss of life, usually within 1 year of age while a second defect of the human LIPA gene generates a milder late-onset cholesteryl ester storage disease (CESD) (Beaudet et al. 1977; Burton and Reed 1981; Hoeg et al. 1984). LIPA is localized on chromosome 10 of the human genome and is highly expressed throughout the body, and contains nine coding exons (Koch et al. 1981; Anderson and Sando 1991; Ameis et al. 1994). Several other acid lipase genes, including LIPF (encoding gastric triacylglycerol lipase), LIPJ (encoding lipase J); and LIPK, LIPM and LIPN (encoding epidermis acid lipases K, M and N), are also located within an acid lipase gene cluster on human chromosome 10 (Bodmer et al. 1987; Deloukas et al. 2004; Toulza et al. 2007). A new acid lipase gene (designated as Lipo) has also been recently reported for mouse and rat genomes (Holmes et al. 2010). The human acid lipase gene cluster encodes enzymes with similar sequences which are distinct from the “neutral lipases”, including endothelial lipase (EL), lipoprotein lipase (LPL) and hepatic lipase (HL), which perform specific role in high-density lipoprotein (HDL), LDL and hepatic lipid metabolism, respectively (Wion et al. 1987; Martin et al. 1988; Cai et al. 1989; Ishimura-Oka et al. 1992; Hirata et al. 1999; Jaye et al. 1999). Cholesterol 25-hydroxylase (CH25H or cholesterol 25-monooxygenase) (EC 1.14.99.38) catalyses the formation of 25-hydroxycholesterol from cholesterol which may serve as a corepressor of cholesterol biosynthetic enymes by blocking sterol regulatory element binding protein processing (Lund et al. 1998). 25-Hydroxysterol is also an activator of gene signalling pathways and an immunoregulatory lipid produced by macrophages to negatively regulate the adaptive immune response in mice (Dwyer et al. 2007; Baumann et al. 2009). CH25H is a member of an enzyme family that utilizes di-iron cofactors to catalyse the hydroxylation of sterol substrates, is encoded by an intronless gene (CH25H) located proximally to LIPA on human chromosome 10 and is an integral membrane protein located in the endoplasmic reticulum of liver and many other tissues of the body (Lund et al. 1998; Deloukas et al. 2004). Epidemiological studies have suggested that cholesterol metabolism plays a role in Alzheimer’s disease (AD) pathogenesis and several of these genes, including LIPA and CH25H, have been investigated as possible risk factors for AD (Riemenschneider et al. 2004; Shownkeen et al. 2004; Shibata et al. 2006). Even though a linkage peak was identified within the relevant linkage region on chromosome 10, LIPA and CH25H gene markers were not significantly associated with susceptibility to AD. This study describes the predicted sequences, structures and phylogeny of several mammalian and other vertebrate LIPA and CH25H genes and compares these results for those previously reported for human (Homo sapiens) and mouse (Mus musculus) LIPA and CH25H (Koch et al. 1981; Anderson and Sando 1991; Ameis et al. 1994; Lund et al. 1998). Bioinformatic methods were used to predict the sequences and structures for vertebrate LIPA and CH25H and gene locations for these genes, using data from the respective genome sequences. Phylogenetic analyses also describe the relationships and potential origins of vertebrate LIPA genes during mammalian and vertebrate evolution in comparison with other acid lipase genes.

Materials and methods

Vertebrate lipase and cholesterol 25-hydroxylase gene and protein bioinformatic identification

BLAST (Basic Local Alignment Search Tool) studies were undertaken using web tools from the National Center for Biotechnology Information (NCBI; http://blast.ncbi.nlm.nih.gov/Blast.cgi Altschul et al. 1997). Non-redundant protein sequence databases for several vertebrate genomes were examined using the blastp algorithm, including the chimpanzee (Pan troglodytes; The Chimpanzee Sequencing Analysis Consortium 2005), macaque monkey (Mucaca mulatta; Rhesus Macaque Genome Sequencing Analysis Consortium 2007) horse (Equus caballus; http://www.broadinstitute.org/mammals/horse), cow (Bos Taurus; http://www.hgsc.bcm.tmc.edu/projects/bovine/), mouse (Mus musculus; Mouse Genome Sequencing Consortium 2002), rat (Rattus norvegicus; Rat Genome Sequencing Project Consortium 2004), guinea pig (Cavia porcellushttp://www.broadinstitute.org/science/projects/mammals-models/guinea-pig/guinea-pig), dog (Canis familiaris; http://www.broadinstitute.org/mammals/dog), chicken (Gallus gallus International Chicken Genome Sequencing Consortium 2004), and frog (Xenopus tropicalis; http://genome.jgi-psf.org/Xentr4/Xentr4.home.html). This procedure produced multiple BLAST “hits” for each of the protein databases which were individually examined and retained in FASTA format, and a record kept was the sequences of predicted mRNAs and encoded LIPA- and CH25H-like proteins. These were derived from annotated genomic sequences using the gene prediction method: GNOMON and predicted sequences with high similarity scores for many of the vertebrate LIPA and CH25H genes and proteins examined (see Table 1). The orangutan (Pongo abelii) and marmoset (Callithrix jacchus) genomes were subjected to BLAT (BLAST-Like Alignment Tool) analysis using the human LIPA protein sequence and the UC Santa Cruz genome browser (http://genome.ucsc.edu/cgi-bin/hgBlat) with the default settings to obtain an Ensembl generated protein sequence (Hubbard et al. 2007). A similar BLAT analysis was conducted of the stickleback fish (Gasterosteus aculeatus) genome [http://genome.ucsc.edu/cgi-bin/hgBlat] using the frog (Xenopus tropicalis) LIPA sequence (see Table 1).
Table 1

Vertebrate lipase A (LIPA) and cholesterol 25-hydroxylase (CH24H) genes and enzymes examined

Lipase geneSpeciesRefSeqGenBank IDUNIPROTAminoChromosomeExonsGene sizepISubunitSignal peptide
EnsemblaIDacidslocation(strand)(bps)(MW)(cleavage site)
Human LIPA Homo sapiens NM_001127605BC012287P3857139910:90,964,568-90,997,3859 (−ve)32,8186.4245,4191-21 (EG-SG)c
Chimp LIPA Pan troglodytes XP_521552aBC012287P3857139910:89,482,403-89,515,8349 (−ve)33,4326.4245,4191-21 (EG-SG)c
Orangutan LIPA Pongo abelii ENSPPYT00000002953d b b 39910:87,901,737-87,934,5559 (−ve)32,8196.4245,4521-21 (EG-SG)c
Rhesus LIPA Macaca mulatta XP_001085160a b b 3999:88,805,255-88,839,4539 (−ve)34,1996.3945,4801-24 (GG-KL)c
Marmoset LIPA Callithrix jacchus 4107.004.ae, f b b 399e4107:158,060-204,0949 (+ve)46,0356.3445,424 b
Mouse LIPA Mus musculus NM_021460BC058064Q9Z0M539719:34,568,473-34,599,3329 (−ve)30,8608.1545,3251-25 (VS-AV)c
Rat LIPA Rattus norvegicus NM_012732BC072532Q641943971:238,468,218-238,497,7469 (−ve)29,5296.3045,0791-25 (IS-AV)c
Guinea Pig LIPA Cavia porcellus XP_001503012a b b 3971:39,069,159-39,103,3819 (+ve)34,2237.2946,3271-22 (RG-KL)c
Horse LIPA Equus caballus XP_001503012a b b 3971:39,069,159-39,103,3819 (+ve)34,2237.2946,3271-22 (RG-KL)c
Cow LIPA Bos taurus NP_001096793aBC146075 b 39926:11,349,737-11,387,2459 (−ve)37,5097.2345,6711-23 (SG-WK)c
Pig LIPA Sus scrofa NP_001116606a b b 399 b b b 7.7545,3471-19 (HS-EA)c
Dog LIPA Canis familaris XP_853280a b b 39826:41,958,963-41,981,5959 (−ve)22,6336.7045,0631-19 (RS-EA)c
Chicken LIPA Gallus gallus XP_426515a b b 4026:20,252,280-20,262,0749 (+ve)9,7958.4445,6101-18 (AG-FT)c
Frog LIPA Xenopus tropicalis NM_001015847BC090136 b 404Sce150:1,826,750-1,838,4499 (+ve)11,7005.8145,4541-17 (LT-DD)c
Stickleback LIPA Gasterosteus aculeatus ENSGACT00000013219d b b 402V:11,755,530-11,758,73210 (−ve)3,2036.0045,0051-17 (LS-GP)e
Fruit Fly Lip3 Drosophila melanogaster NM_057983BT023252O461083943R:9,195,960-9,197,6263 (−ve)1,6675.4044,9011-20 (LA-GS)c
CH25H GeneIntragenic (bps)
Human Homo sapiens NM_003956BC072430O09599227210:90,956,214-90,957,0291 (−ve)8166.7731,7457,539
Rhesus Macaca mulatta XP_001083208a b b 2729:88,797,797-88,798,6121 (−ve)8166.7531,8506,643
Mouse Mus musculus NP_034020BC039919Q9Z0F429819:34,548,723-34,549,6161 (−ve)8947.6734,67218,857
Rat Rattus norvegicus NP_001020586BC097064 b 2981:238,457,437-238,458,3301 (−ve)8947.0734,4149,888
Horse Equus caballus XP_001503057a b b 2701:39,111,964-39,112,7731 (+ve)8106.7331,4648,613
Cow Bos taurus NP_001068711BC120312 b 27026:11,336,966-11,337,7751 (−ve)8106.8831,32611,972
Dog Canis familaris XP_543596a b b 27026:41,949,857-41,950,6661 (−ve)8108.8830,4268,297
Chicken Gallus gallus XP_421660a b b 2746:20,415,141-20,415,9621 (−ve)8228.1532,456163,682
Frog Xenopus tropicalis sc.150.119e, f b b 272Sce150:1,998,638-1,999,4531 (−ve)8168.6131,405158,189

aRefSeq The reference mRNA sequence; predicted Ensembl mRNA sequence and GenBank mRNA (or cDNA) IDs are shown (see http://www.ncbi.nlm.nih.gov)

bResult not available

cCleavage site predicted for signal peptide at N-termini

dEnsembl gene prediction

eN-scan gene prediction using the software from the Computational Genomics Lab at Washington University in St. Louis, MO, USA (see http://genome.ucsc.edu)

fContig ID given; UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual LIPA, other acid lipase or CH25H subunits (see http://kr.expasy.org)

bps base pairs of nucleotide sequences

pI Theoretical isoelectric points the number of coding exons are listed

Sources for LIPA and CH25H sequences were provided by the above sources

Vertebrate lipase A (LIPA) and cholesterol 25-hydroxylase (CH24H) genes and enzymes examined aRefSeq The reference mRNA sequence; predicted Ensembl mRNA sequence and GenBank mRNA (or cDNA) IDs are shown (see http://www.ncbi.nlm.nih.gov) bResult not available cCleavage site predicted for signal peptide at N-termini dEnsembl gene prediction eN-scan gene prediction using the software from the Computational Genomics Lab at Washington University in St. Louis, MO, USA (see http://genome.ucsc.edu) fContig ID given; UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual LIPA, other acid lipase or CH25H subunits (see http://kr.expasy.org) bps base pairs of nucleotide sequences pI Theoretical isoelectric points the number of coding exons are listed Sources for LIPA and CH25H sequences were provided by the above sources BLAT analyses were then undertaken for each of the predicted LIPA and CH25H amino acid sequences using the UC Santa Cruz web browser (http://genome.ucsc.edu/cgi-bin/hgBlat) (Kent et al. 2003) with the default settings to obtain the predicted locations for each of the vertebrate LIPA and CH25H genes, including predicted exon boundary locations and gene sizes. BLAT analyses were also performed of human LIPF, LIPJ, LIPK, LIPM and LIPN genes and the mouse Lipo1-like gene using previously reported sequences for encoded subunits in each case (see Table 1). Structures for the major human LIPA and CH25H isoforms (gene splicing variants) were obtained using the AceView website to examine the predicted gene structures using the human LIPA and CH25H genes to interrogate the database of human mRNA sequences (Thierry-Mieg and Thierry-Mieg 2006) (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/index.html?human). Predicted transcription factor binding sites (TFBS) and CpG islands for human LIPA and CH25H genes were identified using the UC Santa Cruz web browser (http://genome.ucsc.edu/cgi-bin/hgBlat) (Kent et al. 2003).

Predicted structures and properties for vertebrate LIPA subunits

Predicted structures for vertebrate LIPA subunits were obtained using the SWISS MODEL web tools (http://swissmodel.expasy.org), respectively (Kopp and Schwede 2004). The reported tertiary structure for dog LIPF (Roussel et al. 2002) served as the reference for the predicted vertebrate LIPA tertiary structures, with a modeling range of residues 24–395. Theoretical isoelectric points and molecular weights for vertebrate LIPA and CH25H subunits were obtained using Expasy web tools (http://au.expasy.org/tools/pi_tool.html). SignalP 3.0 web tools were used to predict the presence and location of signal peptide cleavage sites (http://www.cbs.dtu.dk/services/SignalP/) for each of the predicted vertebrate LIPA sequences (Emmanuelsson et al. 2007). The NetNGlyc 1.0 Server was used to predict potential N-glycosylation sites for vertebrate LIPA subunits (http://www.cbs.dtu.dk/services/NetNGlyc/).

Predicted transmembrane structures for vertebrate CH25H subunits

Predicted transmembrane structures for vertebrate CH25H subunits were obtained using the web server (http://www.cbs.dtu.dk/services/TMHMM-2.0) provided by the Center for Biological Sequence Analysis of the Technical University of Denmark (Krogh and Larsson 2001).

Phylogenetic studies and sequence divergence

Alignments of protein sequences were assembled using BioEdit v.5.0.1 and the default settings (Hall 1999). Alignment ambiguous regions, including the amino and carboxyl termini, were excluded prior to phylogenetic analysis yielding alignments of 365 residues for comparisons of vertebrate LIPA; human LIPJ; human, mouse and rat LIPF, LIPK, LIPM and LIPN; mouse and rat LIPO;1 and Drosophila melanogaster LIP3 sequences (Table 1; Supplementary Table 1). Evolutionary distances were calculated using the Kimura option (Kimura 1983) in TREECON (Van De Peer and de Wachter 1994). Phylogenetic trees were constructed from evolutionary distances using the neighbor-joining method (Saitou and Nei 1987) and were rooted using the Drosophila melanogaster LIP3 sequence. Tree topology was reexamined by the boot-strap method (100 bootstraps were applied) of resampling (Felsenstein 1985).

Results and discussion

Alignments of vertebrate LIPA amino acid sequences

The amino acid sequences of derived LIPA subunits are shown in Fig. 1 together with previously reported sequences for human and mouse LIPA (Anderson and Sando 1991; Ameis et al. 1994; Du et al. 1996). Alignments of human LIPA with other predicted vertebrate LIPA sequences showed 64–98% identities, whereas lower levels of identities were observed with human LIPF, LIPJ, LIPK, LIPM and LIPN and with mouse LIPO1 sequences (49–63% identities), and with the Drosophila melanogaster LIP3 sequence (38% identity) (alignments of vertebrate LIPA sequences with human and mouse acid lipase gene families are not shown) (Table 2). This comparison suggested that the vertebrate subunits identified were all products of a single gene family (LIPA) which is distinct from those previously described for mammalian LIPF, LIPJ, LIPK, LIPM and LIPN gene families (Bodmer et al. 1987; Toulza et al. 2007; Hirata et al. 1999; Jaye et al. 1999; Wion et al. 1987; Martin et al. 1988) and for a new rodent acid lipase gene family, designated as Lipo (Holmes et al. 2010).
Fig. 1

Amino acid sequence alignments for vertebrate LIPA sequences. HuA human LIPA, RhA rhesus LIPA, HoA horse LIPA, MoA mouse LIPA, RaA rat LIPA, CoA cow LIPA, DoA dog LIPA, ChA chicken LIPA, XeA frog LIPA. See Table 1 for sources of LIPA sequences, * identical residues, colan 1 or 2 conservative substitutions, dot 1 or 2 non-conservative substitutions; residues involved in processing at N-terminus (signal peptide), potential N-glycosylation sites including residues NKT (161–163) which serves as a lysosomal targeting sequence, active site residues Ser174, Asp345, and His374 disulfide bond C residues for human LIPA, helix (human LIPA) or predicted helix; Sheet (human LIPA) or predicted sheet, possible basic amino acid “patch” for lysosomal targeting, bold underlined font shows known or predicted exon junctions

Table 2

Percentage identities for vertebrate LIPA, human LIPF, LIPJ, LIPK, LIPM and LIPN, mouse LIPO1 and fruit fly (Drosophila melanogaster) LIP3 amino acid sequences

Acid lipase geneHuman LIPARhesus LIPAMouse LIPAChicken LIPAFrog LIPAHuman LIPFHuman LIPJHuman LIPKHuman LIPMHuman LIPNMouse LIPO1Fruit fly LIP3
Human LIPA100 98 77 72 69 61535963554938
Rhesus LIPA 98 100 78 71 69 60535963554937
Mouse LIPA 77 78 100 65 64 55495558524738
Chicken LIPA 72 71 65 100 75 62546063554838
Frog LIPA 69 69 64 75 10059525864535037
Human LIPF6160556259100556655535037
Human LIPJ5353495452551005751484633
Human LIPK5959556058665710057525132
Human LIPM6363586364555157100544935
Human LIPN5555525553534852541004432
Mouse LIPO149494748504651494410035
Fruit Fly LIP33837383837373332353235100

Numbers show the percentage of amino acid sequence identities. Numbers in bold show higher sequence identities for vertebrate LIPA sequences

Amino acid sequence alignments for vertebrate LIPA sequences. HuA human LIPA, RhA rhesus LIPA, HoA horse LIPA, MoA mouse LIPA, RaA rat LIPA, CoA cow LIPA, DoA dog LIPA, ChA chicken LIPA, XeA frog LIPA. See Table 1 for sources of LIPA sequences, * identical residues, colan 1 or 2 conservative substitutions, dot 1 or 2 non-conservative substitutions; residues involved in processing at N-terminus (signal peptide), potential N-glycosylation sites including residues NKT (161–163) which serves as a lysosomal targeting sequence, active site residues Ser174, Asp345, and His374 disulfide bond C residues for human LIPA, helix (human LIPA) or predicted helix; Sheet (human LIPA) or predicted sheet, possible basic amino acid “patch” for lysosomal targeting, bold underlined font shows known or predicted exon junctions Percentage identities for vertebrate LIPA, human LIPF, LIPJ, LIPK, LIPM and LIPN, mouse LIPO1 and fruit fly (Drosophila melanogaster) LIP3 amino acid sequences Numbers show the percentage of amino acid sequence identities. Numbers in bold show higher sequence identities for vertebrate LIPA sequences The predicted amino acid sequences for these vertebrate LIPA subunits were all of similar length (397–404 residues) and shared many (~34%) of identically aligned residues (Fig. 1; Table 1). In addition, key residues previously described for human gastric acid lipase (LIPF) (Roussel et al. 1999) and for human LIPA (Zschenker et al. 2004) involved in catalysis and maintaining enzyme structure were conserved. Those retained for catalytic function included the active site residues involved with the charge relay system (human LIPA residue numbers used) (Ser174; Asp345; His374); the active site motif (Gly-Xaa-Ser-Yaa-Gly) (residues 172–176); and cysteine residues forming a disulfide bond (Cys248/Cys257) to support the enzyme’s structure. The hydrophobic N-terminus signal peptide function (residues 1–18 for human LIPA), the mannose-6-phosphate containing N-glycosylation site (residues 161–163: Asn-Lys-Thr) and the C-terminal sequence (residues 396–397 Arg-Lys for human LIPA), which may contribute to the lysosomal targeting of LIPA (Sleat et al. 2006), have been retained or underwent conservative substitution(s) for all vertebrate LIPA sequences examined (with the exception of the chicken LIPA C-terminal sequence) (residues 399–400 Ile-Lys) (Fig. 1). Two of the other high probability N-glycosylation sites for human LIPA (Asn36-Val37-Ser38 and Asn273-274Met-275Ser) were retained for all of the vertebrate LIPA sequences examined, while another was conserved for some vertebrate LIPA sequences (Asn72-His73-Ser74) (Fig. 1; Table 3). There were species differences observed for the theoretical isoelectric points (pI) of the vertebrate LIPA subunits, with predicted higher values (pI values >8) for mouse and chicken LIPA (Table 1).
Table 3

Predicted N-glycosylation sites for vertebrate LIPA subunits

Vertebrate LIPA proteinSpeciesSite 1Site 2Site 3Site 4Site 5Site 6PotentialN-glycosylation sitesHighprobability sites (>0.75)Lowerprobability sites (0.5–0.74)
Human Homo sapiens 36NVS 72NHS 101NSS 161NKT 273NMS 321NQS6 4 2
Rhesus Macaca mulatta 36NVS 72NHS 101NSS 161NKT 273NMS 321NQS6 4 2
Mouse Mus musculus 34NVT 99NSS 159NKT 271NMS 319NQS5 3 2
Rat Rattus norvegicus 34NVT 99NSS 159NKT 271NMS 319NQS5 3 2
Horse Equus caballus 34NVS 99NSS 159NKT 271NMS 319NQS5 3 2
Cow Bos taurus 36NVS 72NRS 101NSS 161NKT 273NMS 321NQS6 4 2
Dog Canis familiaris 36NVS 100NSS160NKT 272NMS 320NQT5 2 3
Chicken Gallus gallus 43NVS107NNS167NKT 277NTS 324NQT5 1 4
Frog Xenopus tropicalis 43NIS107NNS 279NMS 326NQT4 1 3
Fish Gasterosteus aculeatus 39NIS 277NMT 324NQS3 2 0

Numbers refer to amino acids in the LIPA sequences, including N asparagine, K lysine, I isoleucine, M methionine, H histidine; S serine, R arginine, T threonine, Q glutamine, and V valine. Note that there are six potential sites identified. High (in bold) and lower probability N-glycosylation sites were identified using the NetNGlyc 1.0 web server (http://www.cbs.dtu.dk/services/NetNGlyc/)

Predicted N-glycosylation sites for vertebrate LIPA subunits Numbers refer to amino acids in the LIPA sequences, including N asparagine, K lysine, I isoleucine, M methionine, H histidine; S serine, R arginine, T threonine, Q glutamine, and V valine. Note that there are six potential sites identified. High (in bold) and lower probability N-glycosylation sites were identified using the NetNGlyc 1.0 web server (http://www.cbs.dtu.dk/services/NetNGlyc/)

Alignments of vertebrate CH25H amino acid sequences

Amino acid sequence alignments of derived CH25H subunits are shown in Fig. 2 together with previously reported sequences for human and mouse CH25H (Lund et al. 1998; Zhao et al. 2005). Most of the vertebrate CH25H sequences were 270–274 amino acid residues in length, with the exception of mouse and rat CH25H which exhibited extended C-termini, and contained 298 residues. Three histidine boxes reported for human CH25H (Lund et al. 1998) have been conserved for all vertebrate CH25H sequences examined, including box 1 (Trp-His-Leu/Val-Leu-Val-His-His) for residues 142–148; box 2 (Phe/Ile-His-Lys-Val/Met/Leu-His-His) for residues 157–162; and box 3 (HisHis-Asp-Leu/Met-His-His) for residues 238–244 (Fig. 2). These have been previously shown to be essential for CH25H catalytic activity and bind the iron atoms which assist in the hydroxylation reaction (Fox et al. 1994). Predicted transmembrane structures for vertebrate CH25H are also shown (Fig. 2), for which three such regions were predominantly retained for the sequences examined. Figure 3 examines in more detail the predicted positioning of the three transmembrane domains within the human CH25H sequence which suggest that the N-terminus commences outside the endoplasmic reticulum, and that the three active site histidine boxes are localized inside the membrane of the endoplasmic reticulum, where CH25H catalysis is likely to take place.
Fig. 2

Amino acid sequence alignments for vertebrate CH25H sequences. HuCH25H Human CH25H, RhCH25H rhesus CH25H, MoCH25H mouse CH25H, RaCH25H rat CH25H, CoCH25H cow CH25H, HoCH25H horse CH25H, ChCH25H chicken CH25H, XeCH25H frog CH25H. See Table 1 for sources of CH25H sequences. * identical residues; colon 1 or 2 conservative substitutions, dot 1 or 2 non-conservative substitutions, histidine residues active site boxes 1, 2 and 3, predicted helix, predicted sheet, predicted transmembrane regions, bold underlined font shows known or predicted exon junctions (single exon CH25H genes observed in each case)

Fig. 3

Predicted locations for transmembrane regions for human CH25H. The graph shows probability (0–1 on y axis) of transmembrane regions (TrM1, TrM2 and TrM3 shown in red) for the human CH25H amino acid sequence (on x axis). Predicted outside membrane CH25H residues are shown in red; predicted inside membrane CH25H residues are shown in blue, predicted positioning of the three histidine active site boxes are shown as H..HH or HH..HH and are localized inside the membrane

Amino acid sequence alignments for vertebrate CH25H sequences. HuCH25H Human CH25H, RhCH25H rhesus CH25H, MoCH25H mouse CH25H, RaCH25H rat CH25H, CoCH25H cow CH25H, HoCH25H horse CH25H, ChCH25H chicken CH25H, XeCH25H frog CH25H. See Table 1 for sources of CH25H sequences. * identical residues; colon 1 or 2 conservative substitutions, dot 1 or 2 non-conservative substitutions, histidine residues active site boxes 1, 2 and 3, predicted helix, predicted sheet, predicted transmembrane regions, bold underlined font shows known or predicted exon junctions (single exon CH25H genes observed in each case) Predicted locations for transmembrane regions for human CH25H. The graph shows probability (0–1 on y axis) of transmembrane regions (TrM1, TrM2 and TrM3 shown in red) for the human CH25H amino acid sequence (on x axis). Predicted outside membrane CH25H residues are shown in red; predicted inside membrane CH25H residues are shown in blue, predicted positioning of the three histidine active site boxes are shown as H..HH or HH..HH and are localized inside the membrane

Comparative vertebrate LIPA and CH25H genomics

The AceView web browser defines the human LIPA gene by 1443 GenBank accessions from cDNA clones derived from spleen, brain, liver and many other tissues and reports a high expression level (~4.9 times the average human gene) (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/) (Thierry-Mieg and Thierry-Mieg 2006). Human LIPA transcripts included 22 alternatively spliced variants, which differed by truncations of the 5′ or 3′ ends, the presence or absence of 10 cassette exons, or had overlapping exons with different boundaries. Of these, five encoded complete proteins, including isoform LIPAb (RefSeq NM_00235) shown in Fig. 4. The predicted 38.47 kb sequence contained ten premessenger exons and nine coding exons as well as several transcription factor binding sites (TFBS) and a CpG island (designated as CpG45) within the 5′-untranslated region for the human LIPA gene (Fig. 4). Figure 1 compares the locations of the intron–exon boundaries for the vertebrate LIPA gene products examined. Exon 1 corresponded to the encoded signal peptide in each case, and exon 4 encoded the lysosomal targeting sequence (for human LIPA residues 161–163 Asn-Lys-Thr) (Sleat et al. 2006). There is identity or near identity for the intron–exon boundaries for each of the vertebrate LIPA genes suggesting conservation of these exons during vertebrate evolution.
Fig. 4

Gene structures and tandem locations for the human CH25H and LIPA genes on chromosome 10 derived from the AceView website http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/, (Reimenschneider et al. 2004); isoform variant LIPAb and CH25H mRNAs are shown with capped 5′- and validated 3′-ends for the predicted sequences, predicted exon regions are shaded, note that CH25H is predicted as a single exon gene, 5′UTR and 3′UTR refer to untranslated 5′ and 3′ regions, respectively, predicted transcription factor binding sites are shown. NKX25 homeobox protein 2.5, RP58 transcriptional repressor RP58, ROAZ zinc finger protein 423, TAXCREB, CREBP1 and CREBP1C cyclic-AMP responsive element-binding proteins, PPARG peroxisome proliferator-activated receptor gamma, HNF4 hepatocyte nuclear factor 4-alpha, COMP1 muscle specific transcription enhancer, HNF3B hepatocyte nuclear factor 3-beta, GFI1 zinc finger protein GFI1, RORA2 alpha orphan nuclear receptor, EVI1 zinc finger protein EVI1, FREAC4 forkhead box protein, STAT3 identified in the promoters of acute-phase genes, HEN1 helix-loop-helix protein 1, and OCT1 transcription factor that binds to the octomer motif, predicted locations for CpG islands (CPG45; CPG33) are shown by shaded triangles

Gene structures and tandem locations for the human CH25H and LIPA genes on chromosome 10 derived from the AceView website http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/, (Reimenschneider et al. 2004); isoform variant LIPAb and CH25H mRNAs are shown with capped 5′- and validated 3′-ends for the predicted sequences, predicted exon regions are shaded, note that CH25H is predicted as a single exon gene, 5′UTR and 3′UTR refer to untranslated 5′ and 3′ regions, respectively, predicted transcription factor binding sites are shown. NKX25 homeobox protein 2.5, RP58 transcriptional repressor RP58, ROAZ zinc finger protein 423, TAXCREB, CREBP1 and CREBP1C cyclic-AMP responsive element-binding proteins, PPARG peroxisome proliferator-activated receptor gamma, HNF4 hepatocyte nuclear factor 4-alpha, COMP1 muscle specific transcription enhancer, HNF3B hepatocyte nuclear factor 3-beta, GFI1 zinc finger protein GFI1, RORA2 alpha orphan nuclear receptor, EVI1 zinc finger protein EVI1, FREAC4 forkhead box protein, STAT3 identified in the promoters of acute-phase genes, HEN1 helix-loop-helix protein 1, and OCT1 transcription factor that binds to the octomer motif, predicted locations for CpG islands (CPG45; CPG33) are shown by shaded triangles In contrast to human LIPA, the human CH25H gene is defined by only 29 GenBank accessions for the AceView web browser from cDNA clones derived from 14 tissues including pancreas, brain and lung and showed a reduced expression level (~25% of the average human gene) (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/) (Thierry-Mieg and Thierry-Mieg 2006). Moreover, a single human CH25H transcript was recorded covering 1.7 kb of sequence which was intronless and contained a large 5′ untranslated sequence proximally located near the 3′ region of the LIPA gene (Fig. 4), which is consistent with a previous report (Lund et al. 1998). The human CH25H genome sequence contained several predicted TFBS sites and a CpG island (CpG33) located in the intragenic region (~7.5 kb) separating the human CH25H and LIPA genes on chromosome 10. Of particular significance were the CREB (cyclic-AMP response element-binding) binding sites, which may play a role in driving expression from the CH25H promoter (Watters and Nourse 2009). The close proximal location of these genes was also observed for all other mammalian genomes examined (<20 kb) (Table 1), while chicken (Gallus gallus) and frog (Xenopus tropicalis) LIPA and CH25H genes were more distantly located (~160 kb). CpG islands were observed in the human LIPA-CH25H intragenic region and in the 5′-untranslated LIPA region which may reflect roles for these CpG islands in up-regulating gene expression (Saxonov et al. 2006), given their colocation with the LIPA and CH25H promoters.

Secondary and tertiary structures for vertebrate LIPA sequences

Figure 1 shows the secondary structures predicted for vertebrate LIPA sequences. Similar α-helix β-sheet structures were observed for all of the vertebrate LIPA subunits examined, particularly near key residues or functional domains, including the α-helix within the N-terminal signal peptide, the β-sheet and α-helix structures surrounding the active site Ser174 (for human LIPA), the α-helix enclosing the lysosomal targeting signal residues (Asn-Lys-Thr residues 161–163 for human LIPA) and the C-terminal α-helix containing the basic amino acid residue ‘patch’ (residues 396–397 Arg-Lys), which may contribute to LIPA lysosomal microlocalization (Sleat et al. 2006). Predicted LIPA secondary structures, however, may not fully reflect structures in vivo and serve only as a guide to the comparative structures for vertebrate LIPA subunits. The predicted tertiary structures for human, mouse, cow and chicken LIPA were sufficiently similar to the previously reported dog LIPF (gastric acid lipase) structure (Roussel et al. 2002) (Fig. 5) but were based on incomplete sequences for human, mouse and cow LIPA (residues 24–395 for human LIPA). These results suggested that the major structural features for human LIPA recently reported (Roussel et al. 1999) resemble those for other vertebrate LIPA proteins, as well as for the dog gastric LIPF structure.
Fig. 5

Comparison of predicted three-dimensional structures for human, mouse and chicken LIPA subunits with the known structure for dog LIPF (from Roussel et al. 2002). Predicted 3D structures were obtained using the SWISS MODEL (http://swissmodel.expasy.org/workspace/index.php) web site and the predicted amino acid sequences for vertebrate LIPA subunits (see Table 1). The rainbow color code describes the 3D structures from the N- (blue) to C-termini (red color). The structures are based on the known 3D structures for dog LIPF (from Roussel et al. 2002) (with a modeling range of residues 24–395 for human, mouse and chicken LIPA)

Comparison of predicted three-dimensional structures for human, mouse and chicken LIPA subunits with the known structure for dog LIPF (from Roussel et al. 2002). Predicted 3D structures were obtained using the SWISS MODEL (http://swissmodel.expasy.org/workspace/index.php) web site and the predicted amino acid sequences for vertebrate LIPA subunits (see Table 1). The rainbow color code describes the 3D structures from the N- (blue) to C-termini (red color). The structures are based on the known 3D structures for dog LIPF (from Roussel et al. 2002) (with a modeling range of residues 24–395 for human, mouse and chicken LIPA)

Phylogeny of vertebrate LIPA and other human acid lipase genes and proteins

Phylogenetic trees (Fig. 6) were constructed from alignments of vertebrate LIPA-like amino acid sequences with human LIPJ, human; mouse and rat LIPF, LIPJ, LIPK, LIPM and LIPN; and mouse and rat LIPO1 sequences (for further details see Supplementary Table 1; and Holmes et al. 2010). The dendrogram was rooted using a Drosophila melanogaster LIP3 sequence (Pistillo et al. 1998) and showed clustering of all of the LIPA-like sequences which were distinct from the other human and mouse acid lipase gene families. The results were consistent with these acid lipase genes being products of gene duplication events prior to vertebrate evolution, particularly for the LIPA gene family, which is of apparent ancient origin of more than 500 million years ago (Donoghue and Benton 2007). Table 2 summarizes the percentages of identity for these enzymes and shows that vertebrate LIPA sequences are ≥64% identical which is in comparison with the 44–63% identities observed comparing sequence identities between acid lipase families. In addition, more closely related species showed higher levels of sequence identity for LIPA, such as the primate species (human and rhesus monkey) which were 98% identical, as compared with the bird (chicken) and human LIPA sequences, with 72% identical sequences.
Fig. 6

Phylogenetic tree of vertebrate LIPA, other human, mouse and rat acid lipases and Drosophila melanogaster LIP3 sequences. The tree is labeled with the lipase gene family number and the species name. Note the separation of the mammalian LIPF, LIPJ, LIPK, LIPM, LIPN and LIPO family sequences from the vertebrate LIPA family cluster. The Drosophila melanogaster LIP3 sequence was used to root the tree. A genetic distance scale is shown. The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates are shown. Replicate values of 90 or more are highly significant (shown in bold). 100 bootstrap replicates were performed in each case

Phylogenetic tree of vertebrate LIPA, other human, mouse and rat acid lipases and Drosophila melanogaster LIP3 sequences. The tree is labeled with the lipase gene family number and the species name. Note the separation of the mammalian LIPF, LIPJ, LIPK, LIPM, LIPN and LIPO family sequences from the vertebrate LIPA family cluster. The Drosophila melanogaster LIP3 sequence was used to root the tree. A genetic distance scale is shown. The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates are shown. Replicate values of 90 or more are highly significant (shown in bold). 100 bootstrap replicates were performed in each case

Conclusions

Based on this report, we propose that an acid lipase primordial gene predated the appearance of vertebrates and underwent successive gene duplication events generating at least seven acid lipase gene families, namely LIPA (encoding lysosomal lipase), LIPF (encoding gastric lipase) and five other gene families (LIPJ, LIPK, LIPM, LIPN and LIPO), which have been retained as separate vertebrate gene families for more than 500 million years. In addition, it is likely that the LIPA gene family has been conserved throughout vertebrate evolution to serve a major role as an acid lysosomal lipase, given the conservation of key residues and lysosomal targeting sequences for vertebrate LIPA proteins. Below is the link to the electronic supplementary material. Supplementary Table 1 Human, Mouse and Rat Acid Lipases Genes and Enzymes Examined RefSeq: the reference mRNA sequence; ¹predicted Ensembl mRNA sequence; and GenBank mRNA (or cDNA) IDs are shown (see http://www.ncbi.nlm.nih.gov); ²result not available; UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual acid lipase subunits (see http://kr.expasy.org); bps refers to base pairs of nucleotide sequences; the number of coding exons are listed.(XLS 36 kb)
  49 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

3.  Initial sequencing and comparative analysis of the mouse genome.

Authors:  Robert H Waterston; Kerstin Lindblad-Toh; Ewan Birney; Jane Rogers; Josep F Abril; Pankaj Agarwal; Richa Agarwala; Rachel Ainscough; Marina Alexandersson; Peter An; Stylianos E Antonarakis; John Attwood; Robert Baertsch; Jonathon Bailey; Karen Barlow; Stephan Beck; Eric Berry; Bruce Birren; Toby Bloom; Peer Bork; Marc Botcherby; Nicolas Bray; Michael R Brent; Daniel G Brown; Stephen D Brown; Carol Bult; John Burton; Jonathan Butler; Robert D Campbell; Piero Carninci; Simon Cawley; Francesca Chiaromonte; Asif T Chinwalla; Deanna M Church; Michele Clamp; Christopher Clee; Francis S Collins; Lisa L Cook; Richard R Copley; Alan Coulson; Olivier Couronne; James Cuff; Val Curwen; Tim Cutts; Mark Daly; Robert David; Joy Davies; Kimberly D Delehaunty; Justin Deri; Emmanouil T Dermitzakis; Colin Dewey; Nicholas J Dickens; Mark Diekhans; Sheila Dodge; Inna Dubchak; Diane M Dunn; Sean R Eddy; Laura Elnitski; Richard D Emes; Pallavi Eswara; Eduardo Eyras; Adam Felsenfeld; Ginger A Fewell; Paul Flicek; Karen Foley; Wayne N Frankel; Lucinda A Fulton; Robert S Fulton; Terrence S Furey; Diane Gage; Richard A Gibbs; Gustavo Glusman; Sante Gnerre; Nick Goldman; Leo Goodstadt; Darren Grafham; Tina A Graves; Eric D Green; Simon Gregory; Roderic Guigó; Mark Guyer; Ross C Hardison; David Haussler; Yoshihide Hayashizaki; LaDeana W Hillier; Angela Hinrichs; Wratko Hlavina; Timothy Holzer; Fan Hsu; Axin Hua; Tim Hubbard; Adrienne Hunt; Ian Jackson; David B Jaffe; L Steven Johnson; Matthew Jones; Thomas A Jones; Ann Joy; Michael Kamal; Elinor K Karlsson; Donna Karolchik; Arkadiusz Kasprzyk; Jun Kawai; Evan Keibler; Cristyn Kells; W James Kent; Andrew Kirby; Diana L Kolbe; Ian Korf; Raju S Kucherlapati; Edward J Kulbokas; David Kulp; Tom Landers; J P Leger; Steven Leonard; Ivica Letunic; Rosie Levine; Jia Li; Ming Li; Christine Lloyd; Susan Lucas; Bin Ma; Donna R Maglott; Elaine R Mardis; Lucy Matthews; Evan Mauceli; John H Mayer; Megan McCarthy; W Richard McCombie; Stuart McLaren; Kirsten McLay; John D McPherson; Jim Meldrim; Beverley Meredith; Jill P Mesirov; Webb Miller; Tracie L Miner; Emmanuel Mongin; Kate T Montgomery; Michael Morgan; Richard Mott; James C Mullikin; Donna M Muzny; William E Nash; Joanne O Nelson; Michael N Nhan; Robert Nicol; Zemin Ning; Chad Nusbaum; Michael J O'Connor; Yasushi Okazaki; Karen Oliver; Emma Overton-Larty; Lior Pachter; Genís Parra; Kymberlie H Pepin; Jane Peterson; Pavel Pevzner; Robert Plumb; Craig S Pohl; Alex Poliakov; Tracy C Ponce; Chris P Ponting; Simon Potter; Michael Quail; Alexandre Reymond; Bruce A Roe; Krishna M Roskin; Edward M Rubin; Alistair G Rust; Ralph Santos; Victor Sapojnikov; Brian Schultz; Jörg Schultz; Matthias S Schwartz; Scott Schwartz; Carol Scott; Steven Seaman; Steve Searle; Ted Sharpe; Andrew Sheridan; Ratna Shownkeen; Sarah Sims; Jonathan B Singer; Guy Slater; Arian Smit; Douglas R Smith; Brian Spencer; Arne Stabenau; Nicole Stange-Thomann; Charles Sugnet; Mikita Suyama; Glenn Tesler; Johanna Thompson; David Torrents; Evanne Trevaskis; John Tromp; Catherine Ucla; Abel Ureta-Vidal; Jade P Vinson; Andrew C Von Niederhausern; Claire M Wade; Melanie Wall; Ryan J Weber; Robert B Weiss; Michael C Wendl; Anthony P West; Kris Wetterstrand; Raymond Wheeler; Simon Whelan; Jamey Wierzbowski; David Willey; Sophie Williams; Richard K Wilson; Eitan Winter; Kim C Worley; Dudley Wyman; Shan Yang; Shiaw-Pyng Yang; Evgeny M Zdobnov; Michael C Zody; Eric S Lander
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

4.  The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models.

Authors:  Jürgen Kopp; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

5.  The DNA sequence and comparative analysis of human chromosome 10.

Authors:  P Deloukas; M E Earthrowl; D V Grafham; M Rubenfield; L French; C A Steward; S K Sims; M C Jones; S Searle; C Scott; K Howe; S E Hunt; T D Andrews; J G R Gilbert; D Swarbreck; J L Ashurst; A Taylor; J Battles; C P Bird; R Ainscough; J P Almeida; R I S Ashwell; K D Ambrose; A K Babbage; C L Bagguley; J Bailey; R Banerjee; K Bates; H Beasley; S Bray-Allen; A J Brown; J Y Brown; D C Burford; W Burrill; J Burton; P Cahill; D Camire; N P Carter; J C Chapman; S Y Clark; G Clarke; C M Clee; S Clegg; N Corby; A Coulson; P Dhami; I Dutta; M Dunn; L Faulkner; A Frankish; J A Frankland; P Garner; J Garnett; S Gribble; C Griffiths; R Grocock; E Gustafson; S Hammond; J L Harley; E Hart; P D Heath; T P Ho; B Hopkins; J Horne; P J Howden; E Huckle; C Hynds; C Johnson; D Johnson; A Kana; M Kay; A M Kimberley; J K Kershaw; M Kokkinaki; G K Laird; S Lawlor; H M Lee; D A Leongamornlert; G Laird; C Lloyd; D M Lloyd; J Loveland; J Lovell; S McLaren; K E McLay; A McMurray; M Mashreghi-Mohammadi; L Matthews; S Milne; T Nickerson; M Nguyen; E Overton-Larty; S A Palmer; A V Pearce; A I Peck; S Pelan; B Phillimore; K Porter; C M Rice; A Rogosin; M T Ross; T Sarafidou; H K Sehra; R Shownkeen; C D Skuce; M Smith; L Standring; N Sycamore; J Tester; A Thorpe; W Torcasso; A Tracey; A Tromans; J Tsolas; M Wall; J Walsh; H Wang; K Weinstock; A P West; D L Willey; S L Whitehead; L Wilming; P W Wray; L Young; Y Chen; R C Lovering; N K Moschonas; R Siebert; K Fechtel; D Bentley; R Durbin; T Hubbard; L Doucette-Stamm; S Beck; D R Smith; J Rogers
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

6.  Cloning of a unique lipase from endothelial cells extends the lipase gene family.

Authors:  K Hirata; H L Dichek; J A Cioffi; S Y Choi; N J Leeper; L Quintana; G S Kronmal; A D Cooper; T Quertermous
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

7.  Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor.

Authors:  Alain Roussel; Nabil Miled; Liliane Berti-Dupuis; Mireille Rivière; Silvia Spinelli; Patrick Berna; Véronique Gruber; Robert Verger; Christian Cambillau
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

8.  Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest.

Authors:  A Roussel; S Canaan; M P Egloff; M Rivière; L Dupuis; R Verger; C Cambillau
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

9.  A novel endothelial-derived lipase that modulates HDL metabolism.

Authors:  M Jaye; K J Lynch; J Krawiec; D Marchadier; C Maugeais; K Doan; V South; D Amin; M Perrone; D J Rader
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

10.  Genome sequence of the Brown Norway rat yields insights into mammalian evolution.

Authors:  Richard A Gibbs; George M Weinstock; Michael L Metzker; Donna M Muzny; Erica J Sodergren; Steven Scherer; Graham Scott; David Steffen; Kim C Worley; Paula E Burch; Geoffrey Okwuonu; Sandra Hines; Lora Lewis; Christine DeRamo; Oliver Delgado; Shannon Dugan-Rocha; George Miner; Margaret Morgan; Alicia Hawes; Rachel Gill; Robert A Holt; Mark D Adams; Peter G Amanatides; Holly Baden-Tillson; Mary Barnstead; Soo Chin; Cheryl A Evans; Steve Ferriera; Carl Fosler; Anna Glodek; Zhiping Gu; Don Jennings; Cheryl L Kraft; Trixie Nguyen; Cynthia M Pfannkoch; Cynthia Sitter; Granger G Sutton; J Craig Venter; Trevor Woodage; Douglas Smith; Hong-Mei Lee; Erik Gustafson; Patrick Cahill; Arnold Kana; Lynn Doucette-Stamm; Keith Weinstock; Kim Fechtel; Robert B Weiss; Diane M Dunn; Eric D Green; Robert W Blakesley; Gerard G Bouffard; Pieter J De Jong; Kazutoyo Osoegawa; Baoli Zhu; Marco Marra; Jacqueline Schein; Ian Bosdet; Chris Fjell; Steven Jones; Martin Krzywinski; Carrie Mathewson; Asim Siddiqui; Natasja Wye; John McPherson; Shaying Zhao; Claire M Fraser; Jyoti Shetty; Sofiya Shatsman; Keita Geer; Yixin Chen; Sofyia Abramzon; William C Nierman; Paul H Havlak; Rui Chen; K James Durbin; Amy Egan; Yanru Ren; Xing-Zhi Song; Bingshan Li; Yue Liu; Xiang Qin; Simon Cawley; Kim C Worley; A J Cooney; Lisa M D'Souza; Kirt Martin; Jia Qian Wu; Manuel L Gonzalez-Garay; Andrew R Jackson; Kenneth J Kalafus; Michael P McLeod; Aleksandar Milosavljevic; Davinder Virk; Andrei Volkov; David A Wheeler; Zhengdong Zhang; Jeffrey A Bailey; Evan E Eichler; Eray Tuzun; Ewan Birney; Emmanuel Mongin; Abel Ureta-Vidal; Cara Woodwark; Evgeny Zdobnov; Peer Bork; Mikita Suyama; David Torrents; Marina Alexandersson; Barbara J Trask; Janet M Young; Hui Huang; Huajun Wang; Heming Xing; Sue Daniels; Darryl Gietzen; Jeanette Schmidt; Kristian Stevens; Ursula Vitt; Jim Wingrove; Francisco Camara; M Mar Albà; Josep F Abril; Roderic Guigo; Arian Smit; Inna Dubchak; Edward M Rubin; Olivier Couronne; Alexander Poliakov; Norbert Hübner; Detlev Ganten; Claudia Goesele; Oliver Hummel; Thomas Kreitler; Young-Ae Lee; Jan Monti; Herbert Schulz; Heike Zimdahl; Heinz Himmelbauer; Hans Lehrach; Howard J Jacob; Susan Bromberg; Jo Gullings-Handley; Michael I Jensen-Seaman; Anne E Kwitek; Jozef Lazar; Dean Pasko; Peter J Tonellato; Simon Twigger; Chris P Ponting; Jose M Duarte; Stephen Rice; Leo Goodstadt; Scott A Beatson; Richard D Emes; Eitan E Winter; Caleb Webber; Petra Brandt; Gerald Nyakatura; Margaret Adetobi; Francesca Chiaromonte; Laura Elnitski; Pallavi Eswara; Ross C Hardison; Minmei Hou; Diana Kolbe; Kateryna Makova; Webb Miller; Anton Nekrutenko; Cathy Riemer; Scott Schwartz; James Taylor; Shan Yang; Yi Zhang; Klaus Lindpaintner; T Dan Andrews; Mario Caccamo; Michele Clamp; Laura Clarke; Valerie Curwen; Richard Durbin; Eduardo Eyras; Stephen M Searle; Gregory M Cooper; Serafim Batzoglou; Michael Brudno; Arend Sidow; Eric A Stone; J Craig Venter; Bret A Payseur; Guillaume Bourque; Carlos López-Otín; Xose S Puente; Kushal Chakrabarti; Sourav Chatterji; Colin Dewey; Lior Pachter; Nicolas Bray; Von Bing Yap; Anat Caspi; Glenn Tesler; Pavel A Pevzner; David Haussler; Krishna M Roskin; Robert Baertsch; Hiram Clawson; Terrence S Furey; Angie S Hinrichs; Donna Karolchik; William J Kent; Kate R Rosenbloom; Heather Trumbower; Matt Weirauch; David N Cooper; Peter D Stenson; Bin Ma; Michael Brent; Manimozhiyan Arumugam; David Shteynberg; Richard R Copley; Martin S Taylor; Harold Riethman; Uma Mudunuri; Jane Peterson; Mark Guyer; Adam Felsenfeld; Susan Old; Stephen Mockrin; Francis Collins
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

View more
  15 in total

1.  25-Hydroxycholesterol Production by the Cholesterol-25-Hydroxylase Interferon-Stimulated Gene Restricts Mammalian Reovirus Infection.

Authors:  Alexandra Doms; Tatiana Sanabria; Jeanne N Hansen; Nihal Altan-Bonnet; Geoffrey H Holm
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model.

Authors:  Chunfeng Li; Yong-Qiang Deng; Shuo Wang; Feng Ma; Roghiyh Aliyari; Xing-Yao Huang; Na-Na Zhang; Momoko Watanabe; Hao-Long Dong; Ping Liu; Xiao-Feng Li; Qing Ye; Min Tian; Shuai Hong; Junwan Fan; Hui Zhao; Lili Li; Neda Vishlaghi; Jessie E Buth; Connie Au; Ying Liu; Ning Lu; Peishuang Du; F Xiao-Feng Qin; Bo Zhang; Danyang Gong; Xinghong Dai; Ren Sun; Bennett G Novitch; Zhiheng Xu; Cheng-Feng Qin; Genhong Cheng
Journal:  Immunity       Date:  2017-03-14       Impact factor: 31.745

3.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol.

Authors:  Su-Yang Liu; Roghiyh Aliyari; Kelechi Chikere; Guangming Li; Matthew D Marsden; Jennifer K Smith; Olivier Pernet; Haitao Guo; Rebecca Nusbaum; Jerome A Zack; Alexander N Freiberg; Lishan Su; Benhur Lee; Genhong Cheng
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

Review 4.  Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses.

Authors:  Danielle Blondel; Ghizlane Maarifi; Sébastien Nisole; Mounira K Chelbi-Alix
Journal:  Viruses       Date:  2015-07-07       Impact factor: 5.048

5.  Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice.

Authors:  Britta Noebauer; Alexander Jais; Jelena Todoric; Klaus Gossens; Hedwig Sutterlüty-Fall; Elisa Einwallner
Journal:  J Diabetes Res       Date:  2017-02-19       Impact factor: 4.011

Review 6.  Multifaceted Functions of CH25H and 25HC to Modulate the Lipid Metabolism, Immune Responses, and Broadly Antiviral Activities.

Authors:  Jin Zhao; Jiaoshan Chen; Minchao Li; Musha Chen; Caijun Sun
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.048

7.  Cloning, phylogenetic analysis and 3D modeling of a putative lysosomal acid lipase from the camel, Camelus dromedarius.

Authors:  Farid Shokry Ataya
Journal:  Molecules       Date:  2012-08-30       Impact factor: 4.411

8.  Associations of gender and serum total cholesterol with CD4+ T cell count and HIV RNA load in antiretroviral-naïve individuals in Addis Ababa.

Authors:  Melaku Adal; Rawleigh Howe; Desta Kassa; Abraham Aseffa; Beyene Petros
Journal:  BMC Public Health       Date:  2018-07-31       Impact factor: 3.295

Review 9.  Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature.

Authors:  Richard Lathe; Alexandra Sapronova; Yuri Kotelevtsev
Journal:  BMC Geriatr       Date:  2014-03-21       Impact factor: 3.921

10.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Authors:  Marta Futema; Vincent Plagnol; KaWah Li; Ros A Whittall; H Andrew W Neil; Mary Seed; Stefano Bertolini; Sebastiano Calandra; Olivier S Descamps; Colin A Graham; Robert A Hegele; Fredrik Karpe; Ronen Durst; Eran Leitersdorf; Nicholas Lench; Devaki R Nair; Handrean Soran; Frank M Van Bockxmeer; Steve E Humphries
Journal:  J Med Genet       Date:  2014-07-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.